전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
ADCLimited DatastaleAmgenPhase 2

Blinatumomab and Inotuzumab Ozogamicin (Blinatumomab and Inotuzumab Ozogamicin)

Acute Lymphoblastic Leukemia; Immunotherapy · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#ADC#Phase2#antibody-drug-conjugate#Immunotherapy+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBiocon Biologics UK LtdPhase 3

Bmab1200 (Bmab1200)

Moderate to Severe Chronic Plaque Psoriasis · Moderate to Severe Chronic Plaque Psoria

#ModeratetoSevereChronicPlaquePso#Antibody#Phase3#monoclonal-antibody#Biocon
Trials 1Status Active
AntibodyLimited DatastaleBiocon Biologics UK PLCPhase 1

Bmab1800 (Bmab1800)

Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings) · Adult Patients With Stage IIB, IIC, and

#AdultPatientsWithStageIIBIICand#Antibody#Phase1#monoclonal-antibody#AdultPatientsWithStageIIB+3
Trials 1Status Recruiting
AntibodyLimited DatastaleBiocon Biologics UK PLCPhase 1

Bmab3000 (Bmab3000)

Healthy Male Participants · Healthy Male Participants

#HealthyMaleParticipants#Antibody#Phase1#monoclonal-antibody#Biocon
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity of California, San F…Phase 3

Bococizumab (Bococizumab)

Dyslipidemia; Cardiovascular Disease · Dyslipidemia

#Dyslipidemia#Antibody#Phase3#monoclonal-antibody#CardiovascularDisease+1
Trials 1Status Discontinued
AntibodyLimited DatastaleProvidence Health & ServicesPhase 2

Bortezomib, Thymoglobulin, Rituximab, Gamimune N, (IVIG, Bortezomib, Thymoglobulin, Rituximab, Gamimune N,, Bortezomib, Thymoglobulin, Rituximab, Gamimune N, (IVIG), Plasmapheresis)

Heart Transplantation · Heart Transplantation

#HeartTransplantation#Antibody#Phase2#monoclonal-antibody#Providence
Trials 1Status Discontinued
AntibodyLimited DatastaleAstraZenecaPhase 3

Brazikumab high dose (Brazikumab high dose)

Crohn's Disease; IBD · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#monoclonal-antibody#IBD+1
Trials 1Status Discontinued
ADCLimited DatastaleSeagenPreclinical

brentuximab vedotin (Adcetris, Brentuximab Vedotin Plus CHP)

CD30-Positive Peripheral T-Cell Lymphoma · CD30

#CD30#ADC#Preclinical#antibody-drug-conjugate#CD30-PositivePeripheralT-CellLym+1
Trials 1Status Recruiting
ADCLimited DatastaleSeagenPhase 2

brentuximab vedotin (Adcetris, Brentuximab Vedotin+ Bendamustine+Anti-PD-1 antibody)

Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma · PD-1

#PD-1#ADC#Phase2#antibody-drug-conjugate#IneligibleOrRefusedTransplantPat+1
Trials 1Status Recruiting
ADCLimited DatastaleSeagenPhase 1

brentuximab vedotin (Adcetris, Brentuximab vedotin and rifampicin)

Hodgkin Lymphoma; Anaplastic Large-cell Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase1#antibody-drug-conjugate#AnaplasticLarge-cellLymphoma+1
Trials 1Status Active
ADCLimited DatastaleSeagenPreclinical

Brentuximab-Vedotin associated with Bendamustine (Brentuximab-Vedotin associated with Bendamustine)

Relapsed or Refractory Hodgkin Lymphoma · FRα

#FR#ADC#Preclinical#antibody-drug-conjugate#RelapsedorRefractoryHodgkinLymph+1
Trials 1Status Active
CGTLimited DatastaleKitePhase 2

other names: brexu-cel , Tecartus (Brexucabtagene autoleucel, Brexucabtagene autoleucel ( other names: brexu-cel , Tecartus))

Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 1

Brivanib + Cetuximab (Brivanib + Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleRadboud University Medical Cent…Approved

Brodalumab (Brodalumab)

Psoriasis; Psoriasis Vulgaris · Psoriasis

#Psoriasis#Antibody#Approved#monoclonal-antibody#PsoriasisVulgaris+1
Trials 1Status Active
CGTLimited DatastaleInstitute of Hematology & Blood…Phase 1

C-CAR066 (C-CAR066)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 2

cetuximab (C225, C225 (cetuximab))

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#monoclonal-antibody#Sun
Trials 1Status Active
CGTLimited DatastaleShanghai Exuma Biotechnology Lt…Phase 1

C402-CD19-CAR (C402-CD19-CAR)

Diffuse Large B-cell-lymphoma; DLBCL, Nos Genetic Subtypes · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleNational Heart, Lung, and Blood…Phase 1

C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs (C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs)

Human Immunodeficiency Virus 1 Positive; Stage I Adult Hodgkin Lymphoma · Human Immunodeficiency Virus 1 Positive

#HumanImmunodeficiencyVirus1Posit#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleBaylor College of MedicinePhase 1

C7R-GD2.CART cells (C7R-GD2.CART cells)

Relapsed Neuroblastoma; Refractory Neuroblastoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

C7R.CD30.CAR-EBVST cells (C7R.CD30.CAR-EBVST cells)

CD30-Positive Diffuse Large B-Cell Lymphoma; Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting

48 / 103 pages

← PreviousNext →